Background: Chronic inflammatory demyelinating polyradiculoneuropathy - CIDP is a treatable but rare acquired peripheral neuropathy of presumed autoimmune etiology. CIDP is a treatable disorder which is responsive to some immunosuppresors and immunomodulators, particularly corticosteroids, IVIg and plasmapheresis, but therapies must be of lifelong duration.